Contort
发表于 2025-4-1 03:05:03
http://reply.papertrans.cn/29/2844/284374/284374_61.png
旧病复发
发表于 2025-4-1 07:57:39
http://reply.papertrans.cn/29/2844/284374/284374_62.png
得罪人
发表于 2025-4-1 11:21:47
Type 2 Diabetes Mellitus and Dyslipidemia,levels of apolipoprotein B. High levels of LDL cholesterol is the most important modifiable risk factor for CVD in type 2 diabetes, and therefore statin treatment, in addition to diet, is the basis of lipid-lowering treatment. Statin treatment is evidence-based in the prevention of CVD mortality and morbidity in individuals with type 2 diabetes
胆小懦夫
发表于 2025-4-1 17:08:15
Dyslipidemia in Chronic Kidney Disease and Nephrotic Syndrome,sms of lipid abnormalities in kidney disease vary depending on the presence and severity of proteinuria, renal failure, renal replacement modalities (hemodialysis, peritoneal dialysis, and renal transplantation), dietary and drug regimens, and preexistent genetic disorders of lipid metabolism.